Skip to main content
PMC home page
Gut logoLink to Gut
. 2001 Aug;49(2):282–287. doi: 10.1136/gut.49.2.282

Osteoporosis in primary biliary cirrhosis revisited

J Newton 1, R Francis 1, M Prince 1, O James 1, M Bassendine 1, D Rawlings 1, D Jones 1
PMCID: PMC1728382  PMID: 11454807

Abstract

BACKGROUND—Primary biliary cirrhosis (PBC) is increasingly being diagnosed in the earlier non-cholestatic stages of disease. Accepted wisdom has been that PBC is frequently complicated by osteoporosis. Whether this association holds true for the broader spectrum of PBC patients now recognised has not as yet been studied.
AIMS—To examine the extent to which osteoporosis occurs more commonly in PBC patients than in normal individuals of the same age and sex.
DESIGN—Retrospective review of a large cohort of well characterised PBC patients.
PATIENTS—A total of 272 PBC patients with definite or probable PBC followed up for a mean of 10.1 years (total follow up 2726 patient years) who had at least one bone mineral density measurement (BMD).
RESULTS—In this unselected group of PBC patients, mean Z scores (number of SDs from age and sex matched normal mean values) at the neck of femur (NOF) and lumbar spine (LS) at first BMD measurement (7 (6) years after PBC diagnosis) were −0.1 (1.4) and 0.1 (1.4), respectively. At first BMD measurement, 18 PBC patients had Z scores less than −2.0 and 85 had T scores less than −2.5. No factors predictive of osteoporosis were found in affected patients. A total of 957 BMD measurements were performed (0.35 per patient year of follow up); 220 patients had two or more measurements. No patient went on to develop de novo osteoporosis during follow up. In the 51 patients (who were clinically representative of the whole group) who received no PBC or bone related treatment during follow up, %BMD changes per year at the NOF and LS were −1.6 (3.2) and 0.1 (2.2), respectively. No variance in this "natural" rate of BMD measurement was seen in patients receiving PBC modulating agents (including prednisolone and UDCA) or osteoporosis prophylaxis/therapy. Significant improvement at the LS was seen in patients undergoing liver transplantation.
CONCLUSIONS—Osteoporosis is not a specific complication of PBC.


Keywords: liver cirrhosis; primary biliary cirrhosis; osteoporosis

Full Text

The Full Text of this article is available as a PDF (137.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ATKINSON M., NORDIN B. E., SHERLOCK S. Malabsorption and bone disease in prolonged obstructive jaundice. Q J Med. 1956 Jul;25(99):299–312. [PubMed] [Google Scholar]
  2. Almdal T., Schaadt O., Vesterdad Jørgensen J., Lindgreen P., Ranek L. Vitamin D, parathyroid hormone, and bone mineral content of lumbar spine and femur in primary biliary cirrhosis. J Intern Med. 1989 Mar;225(3):207–213. doi: 10.1111/j.1365-2796.1989.tb00065.x. [DOI] [PubMed] [Google Scholar]
  3. Anderson F. H., Francis R. M., Faulkner K. Androgen supplementation in eugonadal men with osteoporosis-effects of 6 months of treatment on bone mineral density and cardiovascular risk factors. Bone. 1996 Feb;18(2):171–177. doi: 10.1016/8756-3282(95)00441-6. [DOI] [PubMed] [Google Scholar]
  4. Eastell R., Dickson E. R., Hodgson S. F., Wiesner R. H., Porayko M. K., Wahner H. W., Cedel S. L., Riggs B. L., Krom R. A. Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology. 1991 Aug;14(2):296–300. [PubMed] [Google Scholar]
  5. Guañabens N., Parés A., Mariñoso L., Brancós M. A., Piera C., Serrano S., Rivera F., Rodés J. Factors influencing the development of metabolic bone disease in primary biliary cirrhosis. Am J Gastroenterol. 1990 Oct;85(10):1356–1362. [PubMed] [Google Scholar]
  6. Hodgson S. F., Dickson E. R., Wahner H. W., Johnson K. A., Mann K. G., Riggs B. L. Bone loss and reduced osteoblast function in primary biliary cirrhosis. Ann Intern Med. 1985 Dec;103(6 ):855–860. doi: 10.7326/0003-4819-103-6-855. [DOI] [PubMed] [Google Scholar]
  7. James O. F., Bhopal R., Howel D., Gray J., Burt A. D., Metcalf J. V. Primary biliary cirrhosis once rare, now common in the United Kingdom? Hepatology. 1999 Aug;30(2):390–394. doi: 10.1002/hep.510300213. [DOI] [PubMed] [Google Scholar]
  8. Janes C. H., Dickson E. R., Okazaki R., Bonde S., McDonagh A. F., Riggs B. L. Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest. 1995 Jun;95(6):2581–2586. doi: 10.1172/JCI117959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jones D. E., James O. F., Bassendine M. F. Primary biliary cirrhosis: clinical and associated autoimmune features and natural history. Clin Liver Dis. 1998 May;2(2):265-82, viii. doi: 10.1016/s1089-3261(05)70007-6. [DOI] [PubMed] [Google Scholar]
  10. Kehayoglou A. K., Holdsworth C. D., Agnew J. E., Whelton M. J., Sherlock S. Bone disease and calcium absorption in primary biliary cirrhosis with special reference to vitamin-D therapy. Lancet. 1968 Apr 6;1(7545):715–718. doi: 10.1016/s0140-6736(68)92164-8. [DOI] [PubMed] [Google Scholar]
  11. Matloff D. S., Kaplan M. M., Neer R. M., Goldberg M. J., Bitman W., Wolfe H. J. Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment. Gastroenterology. 1982 Jul;83(1 Pt 1):97–102. [PubMed] [Google Scholar]
  12. Metcalf J. V., Bhopal R. S., Gray J., Howel D., James O. F. Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England. Int J Epidemiol. 1997 Aug;26(4):830–836. doi: 10.1093/ije/26.4.830. [DOI] [PubMed] [Google Scholar]
  13. Metcalf J. V., Howel D., James O. F., Bhopal R. Primary biliary cirrhosis: epidemiology helping the clinician. BMJ. 1996 May 11;312(7040):1181–1182. doi: 10.1136/bmj.312.7040.1181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mitchison H. C., Malcolm A. J., Bassendine M. F., James O. F. Metabolic bone disease in primary biliary cirrhosis at presentation. Gastroenterology. 1988 Feb;94(2):463–470. doi: 10.1016/0016-5085(88)90438-6. [DOI] [PubMed] [Google Scholar]
  15. Neuberger J. Primary biliary cirrhosis. Lancet. 1997 Sep 20;350(9081):875–879. doi: 10.1016/S0140-6736(97)05419-6. [DOI] [PubMed] [Google Scholar]
  16. Newton J. L., Jones D. E., Metcalf J. V., Park J. B., Burt A. D., Bassendine M. F., James O. F. Presentation and mortality of primary biliary cirrhosis in older patients. Age Ageing. 2000 Jul;29(4):305–309. doi: 10.1093/ageing/29.4.305. [DOI] [PubMed] [Google Scholar]
  17. Scheuer P. Primary biliary cirrhosis. Proc R Soc Med. 1967 Dec;60(12):1257–1260. [PMC free article] [PubMed] [Google Scholar]
  18. Sherlock S., Scheuer P. J. The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med. 1973 Sep 27;289(13):674–678. doi: 10.1056/NEJM197309272891306. [DOI] [PubMed] [Google Scholar]
  19. Stellon A. J., Davies A., Compston J., Williams R. Osteoporosis in chronic cholestatic liver disease. Q J Med. 1985 Nov;57(223):783–790. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES